← All stocks

BioRestorative Therapies, Inc.

BRTX Net buying
CIK 0001505497 #5408 in the set updated 20 Sep 2026
Bought (120 mo)
$3.92M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$23.04K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$23.04K
5 of 5 sales
Net
+$3.90M
+$3.90M against sales at will

By person

11 insiders · 207 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Broadrick Dale
10% owner
$3.28M (104)
$9.63K (4)
+$3.27M
6,747,700
$10.66M
Desmarais John M
Director
$240.00K (1)
+$240.00K
493,398
$779.57K
+31.6%
Silva Francisco
VP of Research and Development
$163.73K (25)
$13.41K (1)
+$150.32K
195,636
$309.10K
ALSTODT LANCE
President, CEO, COB
$138.06K (50)
+$138.06K
187,497
$296.25K
Kristal Robert Eugene
Chief Financial Officer
$45.01K (3)
+$45.01K
7,994
$12.63K
Tonna Paul Jude
Director
$24.10K (3)
+$24.10K
123,850
$195.68K
+1,964%
CATELL ROBERT B
Director
$14.00K (1)
+$14.00K
80,866
$127.77K
+61.7%
Weinreb Mark
CEO and Chairman of the Board
$9.45K (11)
+$9.45K
117,000
$184.86K
+46.3%
Radov A. Jeffrey
Director
$3.19K (4)
+$3.19K
24,500
$38.71K
+96.0%
Ryan Charles S.
Director
42,917
$67.81K
+164.1%
BERGSTEIN ADAM D.
SVP, Planning and Business Dev
2
$3.16
0.0%

No percentages here. This company's share count has moved by a factor of 3.7 over the window, from 6,919,919 to 25,478,170 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Broadrick Dale
28 Oct 2024
10% owner
Sell
1,112
$1.58
$1.76K
Broadrick Dale
1 Dec 2023
10% owner
Sell
250
$1.88
$469.25
Broadrick Dale
27 Nov 2023
10% owner
Sell
278
$1.89
$525.42
Silva Francisco
26 Aug 2022
VP of Research and Development
Sell
3,958
$3.39
$13.41K
Broadrick Dale
26 May 2022
10% owner
Sell
2,000
$3.44
$6.88K

What was left out

Form 4 filings counted 188
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 1,201,178,322
Sales filed before the plan box existed 2
History held since 28 Sep 2016